- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT07643753
Active Airways for Children and Young People With Asthma
The Feasibility of an Exercise and Asthma Educational Programme 'Active Airways' on Health Outcomes in Children and Young People With Asthma With All Severities
What is this study about? The investigators want to see if exercise and education sessions can help children and young people (aged 10-17) with asthma, manage the participants asthma better.
The investigators will place participants that are recruited to this study into one of three groups by a computer (randomly):
Group 1:
Usual Care: Continue with normal asthma treatment.
Group 2:
Education: Usual care + a 45-minute online asthma education class once a week.
Group 3:
Exercise & Education: Usual care + 3 exercise sessions a week and asthma education classes.
Descripción general del estudio
Estado
Condiciones
Intervención / Tratamiento
Descripción detallada
Tipo de estudio
Inscripción (Estimado)
Fase
- No aplica
Contactos y Ubicaciones
Estudio Contacto
- Nombre: Naomi Dayman
- Número de teléfono: 07487506547
- Correo electrónico: nad21@leicester.ac.uk
Ubicaciones de estudio
-
-
-
Leicester, Reino Unido
- University of Leicester
-
Contacto:
- Naomi Dayman
- Número de teléfono: 07487506547
- Correo electrónico: nad21@leicester.ac.uk
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
- Niño
Acepta Voluntarios Saludables
Descripción
Inclusion Criteria:
Willing and able to consent to participate in the trial
Able to understand written and spoken English
A diagnosis of Mild to Moderate Asthma or Severe Asthma based on the European Respiratory Society (ERS)/ American Thoracic Society (ATS) consensus statement on Severe Asthma
Able to participate in a formal exercise programme
Aged 10-17 years
Able to engage in focus groups
Approximately 130cm tall (to be able to complete cardiopulmonary exercise testing (CPET))
Exclusion Criteria:
Self-reported uncontrolled severe exercise-induced breathlessness
Required a course of antibiotics or oral corticosteroids within the 4 weeks prior to the study commencing
Children with severe co-morbidities that will not allow them to participate in an exercise programme e.g. Severe neuromuscular disorders, recent fractures or surgeries, cognitive or behavioural conditions.
Participant is unable or unwilling, in the opinion of the investigator, to give informed consent
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Prevención
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Único
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Sin intervención: Group 1- usual care
Participants will continue to receive usual care from their asthma team/ provider
|
|
|
Comparador activo: Group 2- education
Participants will receive a 12 week education class on exercise
|
education on exercise and asthma
|
|
Comparador activo: Group 3- exercise
Participants will take part in a 12 week interval exercise class
|
education on exercise and asthma
12 week interval exercise training programme and 12 week education on exercise with asthma
Otros nombres:
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Recruitment
Periodo de tiempo: 12 weeks
|
The percentage of children approached who participate in the intervention (recruitment)
|
12 weeks
|
|
Retention
Periodo de tiempo: 12 weeks
|
The percentage of participants that complete the intervention with a retention rate of >70%
|
12 weeks
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Adherence to programme
Periodo de tiempo: 12 weeks
|
Participant engagement measured through attendance rates.
|
12 weeks
|
|
Wrist worn accelerometers
Periodo de tiempo: 12 weeks
|
Device wear time compliance during the 12-week study, aiming for =>10 hours a day
|
12 weeks
|
|
Focus groups on patients experience to barriers to an exercise programme
Periodo de tiempo: 12 weeks
|
Lived experience of the barriers for children with asthma to taking part in an exercise programme, measured through qualitative focus groups.
|
12 weeks
|
|
Health beliefs
Periodo de tiempo: 12 weeks
|
Baseline demographics from participants will be recorded from medical records
|
12 weeks
|
|
Respiratory (throat) samples
Periodo de tiempo: Baseline, 12 weeks, 6 months and 1 year.
|
Throat samples will be taken and microbial analysis for assessing microbial diversity through 16S rRNA sequencing, to provide relative abundance of bacterial groups.
A greater bacterial diversity in the respiratory sample is considered a sign of heathier and more resilient microbial community.
This could lead to fewer asthma exacerbations and better asthma control.
|
Baseline, 12 weeks, 6 months and 1 year.
|
|
Quality of life of participants using the paeditric quality of life inventory (asthma module)
Periodo de tiempo: Baseline, 12 weeks, 6 months and 1 year
|
Measured through the paediatric quality of life asthma module to measure how asthma affects the health-related quality of life using 28 items divided into 4 domains, higher scores mean better quality of life and lower scores mean greater asthma-related impairment.
|
Baseline, 12 weeks, 6 months and 1 year
|
|
Effectiveness of the programme
Periodo de tiempo: Baseline, 12 weeks, 6 months and 1 year.
|
Cardiorespiratory fitness (maximal oxygen uptake measured by VO2 max)
|
Baseline, 12 weeks, 6 months and 1 year.
|
|
Respiratory (nasal) samples
Periodo de tiempo: Baseline, 12 weeks, 6 months and 1 year.
|
Nasal samples will be taken and microbial analysis for assessing microbial diversity through 16S rRNA sequencing, to provide relative abundance of bacterial groups.
A greater bacterial diversity in the respiratory sample is considered a sign of a heathier and more resilient microbial community.
This could lead to fewer asthma exacerbations and better asthma control.
|
Baseline, 12 weeks, 6 months and 1 year.
|
|
Gut samples
Periodo de tiempo: Baseline, 12 weeks, 6 months and 1 year.
|
Stool samples will be taken and microbial analysis for assessing microbial diversity through 16S rRNA sequencing, to provide relative abundance of bacterial groups.
A greater bacterial diversity in the stool sample is considered a sign of heathier and more resilient microbial community which could lead to fewer asthma exacerbations and better asthma control.
|
Baseline, 12 weeks, 6 months and 1 year.
|
|
Focus groups on motivators for an exercise programme
Periodo de tiempo: 12 weeks
|
Lived experience of the motivators for children and young people with asthma to taking part in an exercise programme, measured through qualitative focus groups.
|
12 weeks
|
Colaboradores e Investigadores
Patrocinador
Colaboradores
Investigadores
- Investigador principal: Erol Gaillard, University of Leicester
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Estimado)
Finalización primaria (Estimado)
Finalización del estudio (Estimado)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
Términos MeSH relevantes adicionales
- Enfermedades del sistema inmunológico
- Enfermedades de las vías respiratorias
- Enfermedades pulmonares
- Enfermedades bronquiales
- Enfermedades Pulmonares Obstructivas
- Hipersensibilidad Respiratoria
- Hipersensibilidad, Inmediata
- Hipersensibilidad
- Comportamiento
- Asma
- Actividad del motor
- Actividad motora
- Movimiento
- Fenómenos fisiológicos musculoesqueléticos
- Fenómenos fisiológicos musculoesqueléticos y neuronales
- Preparaciones farmacéuticas
- Técnicas de investigación
- Factores socioeconómicos
- Características de la población
- Tecnología, farmacéutica
- Ejercicio
- Estado educativo
- Formas de dosificación
Otros números de identificación del estudio
- 1068
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .
Ensayos clínicos sobre education
-
Tarsus UniversityTerminadoEducación EnfermeríaPavo
-
Chia-Tzu LineTerminadoDiabetes mellitus tipo 2 (DM2) | Pacientes diabéticos, autocuidado, basada en inteligencia artificial, autoeficaciaPorcelana
-
State University of New York at BuffaloActivo, no reclutando
-
University of Texas at AustinActivo, no reclutandoPrediabetes / Diabetes tipo 2Estados Unidos
-
University of SheffieldUniversity of Liverpool; University of Manchester; University of MelbourneActivo, no reclutandoDesarrollo del lenguajeReino Unido
-
Stanford UniversityNational Institute on Aging (NIA)Activo, no reclutandoLa inactividad físicaEstados Unidos
-
Stanford UniversityTerminadoTrastorno autistaEstados Unidos
-
University of MichiganReuben Phoenix Schostak Fontan Wellness Project FundActivo, no reclutandoFragilidad | Fisiología de Fontan | Enfermedad cardíaca de ventrículo únicoEstados Unidos
-
Duke UniversityTerminadoTratamiento y prevención de la anemia después de la administración de la barra nutricional GudnessIndia
-
University of Texas Southwestern Medical CenterAmerican Heart AssociationTerminadoInsuficiencia Cardíaca SistólicaEstados Unidos